Skip to content

Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.

Combined Effects of Neurodynamics With Proprioceptive Neuromuscular Facilitation Technique on Pain and Range of Motion in Patient With Carpal Tunnel Syndrome.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07573878
Enrollment
48
Registered
2026-05-07
Start date
2025-01-01
Completion date
2025-10-01
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome (CTS)

Keywords

Carpal tunnel syndrome, Median nerve, Neurodynamic, PNF, Range of motion

Brief summary

The goal of this clinical trial is to determine the combined effects of neurodynamics with proprioceptive neuromuscular facilitation technique on reducing pain and improving range of motion in patients with carpal tunnel syndrome. This study evaluates whether neurodynamics combined with PNF is an effective approach in treating CTS compared to baseline treatment, as both techniques are well known for their individual effects. This treatment is given for 2 weeks, 5 days per week with 10 repetitions for each exercise.

Interventions

OTHERNeurodynamic and PNF

These 2 exercises were provided in 10 repetitions for 2 weeks (duration), 5 days per week (frequency). i) PNF techniques used in carpal tunnel treatment includes 1. Rhythmic Initiation 2. Agonistic Reversals. ii) For Neurodynamic (1) Distal nerve tension technique :Hand was placed in six different positions each position maintained for 7 second and have 5 repetitions for each step this is done in median nerve tension technique (2) nerve slide

They were provided with common conservative physical therapy treatment for 2 weeks, 5 days per week, following carpal tunnel syndrome. These treatments included use of a wrist splint, especially at night, along with 10-15 min of cold and ultrasound therapy. Medications like NSAIDs were given for 5 days.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed cases of carpal tunnel syndrome. * Patients having positive Tinel's test and Phalen's test. * Symptoms persisted for at least 4 weeks. * Availability and motivation of patients to participate in a 2-week program.

Exclusion criteria

* Patient with contraindications to rehabilitation treatment. * Patients with a history of previous upper limb surgery. * Patient received steroid injection or have any systemic disease that can influence condition.

Design outcomes

Primary

MeasureTime frameDescription
Quick DASH Questionnaire2nd weekChanges from Baseline Quick DASH questionnaire (Quick Disabilities of the Arm, Shoulder, and Hand) is a concise version of the DASH questionnaire. It consists of 11 items, with each item scored from 1 (no difficulty) to 5 (unable to perform), assessing daily activities, pain, and social functioning, along with optional modules for work or sports/performing arts. The total score ranges from 0 to 100, where 0 indicates no disability and 100 indicates the most severe disability. Score Ranges: 0-20: Minimal disability 21-40: Mild to moderate disability 41-60: Moderate to severe disability 61-100: Extreme disability The score is calculated by summing responses, dividing by the number of items (n), subtracting 1, and multiplying by 25.
Visual Analog Scale2nd weekThe Visual Analog Scale (VAS) is a frequently utilized tool in clinical and research settings to measure subjective experiences like pain. It was first developed in 1921 by psychologists Mary H.S. Hayes and Donald G. Paterson as a "graphic rating" method for subjective assessments, later adopted and adapted for measuring pain and clinical symptoms in the 1960s. It consists of a 10 cm line where patients spot their pain intensity, from 0 "no pain" at one end to 10 "unbearable pain" at the other.

Countries

Pakistan

Contacts

PRINCIPAL_INVESTIGATORArnab Altaf, ppdpt

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026